Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-082792
Filing Date
2026-07-29
Accepted
2026-07-29 16:05:47
Documents
8
Period of Report
2026-07-29

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0299567-6k_purple.htm 6-K 15472
2 NOTICE AND PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS OF PUR ea029956701ex99-1.htm EX-99.1 320116
3 VOTING SLIP FOR HOLDERS OF ORDINARY SHARES ea029956701ex99-2.htm EX-99.2 20318
4 BNY MELLON VOTING INSTRUCTION FORM FOR HOLDERS OF AMERICAN DEPOSITARY SHARES ea029956701ex99-3.htm EX-99.3 5386
5 GRAPHIC ea029956701_ex99-1img1.jpg GRAPHIC 1934
6 GRAPHIC ea029956701_ex99-2img1.jpg GRAPHIC 1934
7 GRAPHIC ea029956701_ex99-3img1.jpg GRAPHIC 582921
8 GRAPHIC ea029956701_ex99-3img2.jpg GRAPHIC 339621
  Complete submission text file 0001213900-26-082792.txt   1638884
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 261217371
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)